acNASH index to diagnosing nonalcoholic steatohepatitis: a prospective derivation and global validation study
acNASH index to diagnosing nonalcoholic steatohepatitis: a prospective derivation and global validation study
Background: there is an unmet need for non-invasive biomarkers for the diagnosis of nonalcoholic steatohepatitis (NASH) in non-specialized settings. We aimed to develop and validate a non-invasive test for diagnosing NASH in individuals with biopsy-proven nonalcoholic fatty liver disease (NAFLD).
Methods: we developed a non-invasive test named the acNASH index that combines serum creatinine and aspartate aminotransferase levels in a derivation cohort of 390 Chinese NAFLD patients admitted to the hepatology center of the First Affiliated Hospital of Wenzhou Medical University (China) between December 2016 and September 2019 and subsequently validated in five external cohorts of different ethnicities of patients with biopsy-confirmed NAFLD (pooled n=1,089).
Findings: the performance of the acNASH index for identifying NASH (defined as NAFLD activity score ≥5 with score of ≥1 for each steatosis, lobular inflammation and ballooning) was good in the derivation cohort with an area under receiver operating characteristics (AUROC) of 0·818 (95%CI 0·777-0·860). A cutoff of acNASH index <4·15 gave a sensitivity (Se) of 91%, a specificity (Sp) of 48% and a negative predictive value (NPV) of 83% for ruling-out NASH, conversely, a cutoff of acNASH >7·73 gave a Sp of 91%, Se of 53% and a positive predictive value (PPV) of 85% for ruling-in NASH. In the pooled validation cohort (n=1,089), the diagnostic performance of the index was also good with AUROC=0·805 (95%CI 0·780-0·830), NPV of 93% for ruling-out NASH and PPV of 73% for ruling-in NASH. Subgroup analyses showed similar performance in patients with diabetes or subjects with normal serum transaminase levels.
Interpretation: the acNASH index shows promising utility as a simple non-invasive biomarker for diagnosing NASH among adults with biopsy-proven NAFLD of different ethnicities from different countries.
Funding: The National Natural Science Foundation of China (82070588), High Level Creative Talents from Department of Public Health in Zhejiang Province (S2032102600032) and Project of New Century 551 Talent Nurturing in Wenzhou.
101145
Wu, Xi-Xi
d4d7c707-9641-47f3-8952-487fcf43842b
Zheng, Kenneth I.
e95c7d7e-5766-4477-b240-c67ee07050fe
Boursier, Jérôme
50166740-8f2d-49c5-a91d-fd0f9fc0747c
Chan, Wah-Kheong
b55249cd-454e-456c-9dd5-970885d477c1
Yilmaz, Yusuf
31ae2752-6bcb-4021-8b75-f8ce78438d3d
Romero-Gómez, Manuel
6ed705a0-09b9-40dc-b1a1-36b77cedcd41
El Kassas, Mohamed
c129ff7a-29fb-46ec-b848-5ea56a321654
Targher, Giovanni
043e0811-b389-4922-974e-22e650212c5f
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
Huang, Zhi-Ming
c1da2f09-8bed-40e1-b153-a23022a2ef62
Zheng, Ming-Hua
4a7fbf35-7672-40df-a01e-70b7be152c9e
November 2021
Wu, Xi-Xi
d4d7c707-9641-47f3-8952-487fcf43842b
Zheng, Kenneth I.
e95c7d7e-5766-4477-b240-c67ee07050fe
Boursier, Jérôme
50166740-8f2d-49c5-a91d-fd0f9fc0747c
Chan, Wah-Kheong
b55249cd-454e-456c-9dd5-970885d477c1
Yilmaz, Yusuf
31ae2752-6bcb-4021-8b75-f8ce78438d3d
Romero-Gómez, Manuel
6ed705a0-09b9-40dc-b1a1-36b77cedcd41
El Kassas, Mohamed
c129ff7a-29fb-46ec-b848-5ea56a321654
Targher, Giovanni
043e0811-b389-4922-974e-22e650212c5f
Byrne, Christopher
1370b997-cead-4229-83a7-53301ed2a43c
Huang, Zhi-Ming
c1da2f09-8bed-40e1-b153-a23022a2ef62
Zheng, Ming-Hua
4a7fbf35-7672-40df-a01e-70b7be152c9e
Wu, Xi-Xi, Zheng, Kenneth I., Boursier, Jérôme, Chan, Wah-Kheong, Yilmaz, Yusuf, Romero-Gómez, Manuel, El Kassas, Mohamed, Targher, Giovanni, Byrne, Christopher, Huang, Zhi-Ming and Zheng, Ming-Hua
(2021)
acNASH index to diagnosing nonalcoholic steatohepatitis: a prospective derivation and global validation study.
EClinicalMedicine, 41 (101145), .
(doi:10.1016/j.eclinm.2021.101145).
Abstract
Background: there is an unmet need for non-invasive biomarkers for the diagnosis of nonalcoholic steatohepatitis (NASH) in non-specialized settings. We aimed to develop and validate a non-invasive test for diagnosing NASH in individuals with biopsy-proven nonalcoholic fatty liver disease (NAFLD).
Methods: we developed a non-invasive test named the acNASH index that combines serum creatinine and aspartate aminotransferase levels in a derivation cohort of 390 Chinese NAFLD patients admitted to the hepatology center of the First Affiliated Hospital of Wenzhou Medical University (China) between December 2016 and September 2019 and subsequently validated in five external cohorts of different ethnicities of patients with biopsy-confirmed NAFLD (pooled n=1,089).
Findings: the performance of the acNASH index for identifying NASH (defined as NAFLD activity score ≥5 with score of ≥1 for each steatosis, lobular inflammation and ballooning) was good in the derivation cohort with an area under receiver operating characteristics (AUROC) of 0·818 (95%CI 0·777-0·860). A cutoff of acNASH index <4·15 gave a sensitivity (Se) of 91%, a specificity (Sp) of 48% and a negative predictive value (NPV) of 83% for ruling-out NASH, conversely, a cutoff of acNASH >7·73 gave a Sp of 91%, Se of 53% and a positive predictive value (PPV) of 85% for ruling-in NASH. In the pooled validation cohort (n=1,089), the diagnostic performance of the index was also good with AUROC=0·805 (95%CI 0·780-0·830), NPV of 93% for ruling-out NASH and PPV of 73% for ruling-in NASH. Subgroup analyses showed similar performance in patients with diabetes or subjects with normal serum transaminase levels.
Interpretation: the acNASH index shows promising utility as a simple non-invasive biomarker for diagnosing NASH among adults with biopsy-proven NAFLD of different ethnicities from different countries.
Funding: The National Natural Science Foundation of China (82070588), High Level Creative Talents from Department of Public Health in Zhejiang Province (S2032102600032) and Project of New Century 551 Talent Nurturing in Wenzhou.
Text
acNASH-MS -R-3
- Accepted Manuscript
Text
acNASH-APPENDICES
- Accepted Manuscript
Text
Table 1-R-3
- Accepted Manuscript
Text
Table 2
- Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
Fig 1
- Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
Fig 2
- Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
Fig 3
- Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
Fig 4
- Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
Fig 5
- Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
Table 3-R-2
- Accepted Manuscript
Restricted to Repository staff only
Request a copy
Text
PIIS2589537021004259 (1)
- Version of Record
Show all 11 downloads.
More information
Accepted/In Press date: 14 September 2021
e-pub ahead of print date: 30 September 2021
Published date: November 2021
Additional Information:
© 2021 The Author(s).
Identifiers
Local EPrints ID: 451614
URI: http://eprints.soton.ac.uk/id/eprint/451614
ISSN: 2589-5370
PURE UUID: 2372b067-b75f-413a-a598-9b3a594e3976
Catalogue record
Date deposited: 14 Oct 2021 16:32
Last modified: 17 Mar 2024 02:49
Export record
Altmetrics
Contributors
Author:
Xi-Xi Wu
Author:
Kenneth I. Zheng
Author:
Jérôme Boursier
Author:
Wah-Kheong Chan
Author:
Yusuf Yilmaz
Author:
Manuel Romero-Gómez
Author:
Mohamed El Kassas
Author:
Giovanni Targher
Author:
Zhi-Ming Huang
Author:
Ming-Hua Zheng
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics